PUBLISHER: Grand View Research | PRODUCT CODE: 2068079
PUBLISHER: Grand View Research | PRODUCT CODE: 2068079
The global wildlife health market size was estimated at USD 2.7 billion in 2025 and is projected to reach USD 5.4 billion by 2033, growing at a CAGR of 9.1% from 2026 to 2033. Some of the factors driving the market growth are rising zoonotic disease surveillance and One Health preparedness programs, government funding for avian influenza preparedness and wildlife protection and expansion of wildlife rehabilitation centers, zoos, and specialized veterinary infrastructure.
Increasing zoonotic disease outbreaks and cross-species transmission risks are driving higher investment in wildlife health surveillance, diagnostics, and preventive care. Governments and international organizations are expanding One Health frameworks linking animal, human, and environmental health, increasing demand for diagnostics, vaccines, and field treatment solutions across wildlife populations. For instance, in April 2026, World Organization for Animal Health stated that nearly 75% of emerging infectious diseases originate in animals, strengthening focus on wildlife disease monitoring and intervention. In addition, the 2026 UN High-Level Meeting on Pandemic Prevention prioritized animal health systems as frontline defenses against future pandemics, accelerating procurement of surveillance tools, veterinary pharmaceuticals, and disease response infrastructure across wildlife health programs.
Moreover, the rising H5 avian influenza preparedness spending is increasing adoption of vaccines, monitoring equipment, rescue consumables, and captive wildlife healthcare services. Wildlife facilities, national parks, and conservation centers are receiving targeted funding for surveillance, quarantine, and emergency response capacity. For instance, in April 2026, the Australian government committed USD 35.9 million to strengthen H5 bird flu preparedness planning, including wildlife surveillance, disease spread analysis, and protection of threatened species. Furthermore, more than USD 100 million was allocated nationally for H5 response preparedness, while 21 facilities received additional funding to protect 26 threatened species in captivity. These investments are expanding procurement across the market.
In addition, growth in zoological institutions, rehabilitation centers, and wildlife referral hospitals is increasing continuous demand for pharmaceuticals, anesthesia systems, monitoring devices, and specialized veterinary care. The captive facilities require routine disease management, emergency care, surgical intervention, and preventive vaccination programs for mammals, birds, reptiles, and aquatic species. For instance, in 2025-2026, multiple regions expanded wildlife hospital infrastructure to improve emergency response and specialized treatment capacity, particularly for threatened and rescued species. Furthermore, institutions are increasing procurement of critical care consumables, rescue equipment, and research tools for rehabilitation and conservation programs. This expansion of organized wildlife care facilities is creating sustained long-term demand across the market, particularly within captive facility end users.
Global Wildlife Health Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the wildlife health market report based on product, animal, end use, sales channel, and region.